196 related articles for article (PubMed ID: 35228150)
1. Assessing the association between Corporate Financial Influence and implementation of policies to tackle commercial determinants of non-communicable diseases: A cross-sectional analysis of 172 countries.
Allen LN; Wigley S; Holmer H
Soc Sci Med; 2022 Mar; 297():114825. PubMed ID: 35228150
[TBL] [Abstract][Full Text] [Related]
2. Non-communicable disease policy implementation from 2014 to 2021: a repeated cross-sectional analysis of global policy data for 194 countries.
Allen LN; Wigley S; Holmer H; Barlow P
Lancet Glob Health; 2023 Apr; 11(4):e525-e533. PubMed ID: 36925173
[TBL] [Abstract][Full Text] [Related]
3. Study protocol: assessing the association between corporate financial influence and implementation of policies to tackle commercial determinants of non-communicable diseases: a cross-sectional analysis of 172 countries.
Allen LN; Wigley S; Holmer H
BMJ Open; 2022 Aug; 12(8):e055656. PubMed ID: 36041766
[TBL] [Abstract][Full Text] [Related]
4. Implementation of non-communicable disease policies from 2015 to 2020: a geopolitical analysis of 194 countries.
Allen LN; Wigley S; Holmer H
Lancet Glob Health; 2021 Nov; 9(11):e1528-e1538. PubMed ID: 34678197
[TBL] [Abstract][Full Text] [Related]
5. Implementation of non-communicable disease policies: a geopolitical analysis of 151 countries.
Allen LN; Nicholson BD; Yeung BYT; Goiana-da-Silva F
Lancet Glob Health; 2020 Jan; 8(1):e50-e58. PubMed ID: 31813787
[TBL] [Abstract][Full Text] [Related]
6. Non-communicable disease prevention policy process in five African countries.
Juma PA; Mohamed SF; Matanje Mwagomba BL; Ndinda C; Mapa-Tassou C; Oluwasanu M; Oladepo O; Abiona O; Nkhata MJ; Wisdom JP; Mbanya JC
BMC Public Health; 2018 Aug; 18(Suppl 1):961. PubMed ID: 30168393
[TBL] [Abstract][Full Text] [Related]
7. Barriers and Opportunities for WHO "Best Buys" Non-communicable Disease Policy Adoption and Implementation From a Political Economy Perspective: A Complexity Systematic Review.
Loffreda G; Arakelyan S; Bou-Orm I; Holmer H; Allen LN; Witter S; Ager A; Diaconu K
Int J Health Policy Manag; 2024; 13():7989. PubMed ID: 38618832
[TBL] [Abstract][Full Text] [Related]
8. Strengthening implementation of diet-related non-communicable disease prevention strategies in Fiji: a qualitative policy landscape analysis.
Mounsey S; Waqa G; McKenzie B; Reeve E; Webster J; Bell C; Thow AM
Global Health; 2022 Sep; 18(1):79. PubMed ID: 36050736
[TBL] [Abstract][Full Text] [Related]
9. Baseline status of policy and legislation actions to address non communicable diseases crisis in the Pacific.
Win Tin ST; Kubuabola I; Ravuvu A; Snowdon W; Durand AM; Vivili P; Passmore E
BMC Public Health; 2020 May; 20(1):660. PubMed ID: 32398159
[TBL] [Abstract][Full Text] [Related]
10. Engaging with the Private Sector for Noncommunicable Disease Prevention and Control: Is it Possible to Create "Shared Value?".
Collins TE; Akselrod S; Mahy L; Poznyak V; Berlina D; Hatefi A; Allen L
Ann Glob Health; 2023; 89(1):46. PubMed ID: 37425141
[TBL] [Abstract][Full Text] [Related]
11. Non-communicable disease governance in the era of the sustainable development goals: a qualitative analysis of food industry framing in WHO consultations.
Lauber K; Ralston R; Mialon M; Carriedo A; Gilmore AB
Global Health; 2020 Aug; 16(1):76. PubMed ID: 32847604
[TBL] [Abstract][Full Text] [Related]
12. The evolution of non-communicable diseases policies in post-apartheid South Africa.
Ndinda C; Ndhlovu TP; Juma P; Asiki G; Kyobutungi C
BMC Public Health; 2018 Aug; 18(Suppl 1):956. PubMed ID: 30168397
[TBL] [Abstract][Full Text] [Related]
13. Big food and the World Health Organization: a qualitative study of industry attempts to influence global-level non-communicable disease policy.
Lauber K; Rutter H; Gilmore AB
BMJ Glob Health; 2021 Jun; 6(6):. PubMed ID: 34117011
[TBL] [Abstract][Full Text] [Related]
14. Assessing the progress on the implementation of policy and legislation actions to address the Non-Communicable Diseases crisis in the Pacific.
Win Tin ST; Kubuabola I; Snowdon W; Cash HL; Na'ati E; Waqa GD; Moadsiri A; Bertrand S; Ravuvu A
PLoS One; 2022; 17(8):e0272424. PubMed ID: 35951506
[TBL] [Abstract][Full Text] [Related]
15. Identifying key factors for successful formulation and implementation of healthcare policies on non-communicable diseases: a multinational analysis.
Babaita AO; Jahan Y; Nakamura R; Moriyama M
Front Public Health; 2024; 12():1292176. PubMed ID: 38389939
[TBL] [Abstract][Full Text] [Related]
16. Systems Thinking as a Framework for Analyzing Commercial Determinants of Health.
Knai C; Petticrew M; Mays N; Capewell S; Cassidy R; Cummins S; Eastmure E; Fafard P; Hawkins B; Jensen JD; Katikireddi SV; Mwatsama M; Orford J; Weishaar H
Milbank Q; 2018 Sep; 96(3):472-498. PubMed ID: 30277610
[TBL] [Abstract][Full Text] [Related]
17. How Neoliberalism Is Shaping the Supply of Unhealthy Commodities and What This Means for NCD Prevention.
Lencucha R; Thow AM
Int J Health Policy Manag; 2019 Sep; 8(9):514-520. PubMed ID: 31657174
[TBL] [Abstract][Full Text] [Related]
18. Healthy people and healthy profits? Elaborating a conceptual framework for governing the commercial determinants of non-communicable diseases and identifying options for reducing risk exposure.
Buse K; Tanaka S; Hawkes S
Global Health; 2017 Jun; 13(1):34. PubMed ID: 28619031
[TBL] [Abstract][Full Text] [Related]
19. The dynamic of non-communicable disease control policy in Indonesia.
Christiani Y; Dugdale P; Tavener M; Byles JE
Aust Health Rev; 2017 May; 41(2):207-213. PubMed ID: 27209156
[TBL] [Abstract][Full Text] [Related]
20. Addressing NCDs: Challenges From Industry Market Promotion and Interferences.
Tangcharoensathien V; Chandrasiri O; Kunpeuk W; Markchang K; Pangkariya N
Int J Health Policy Manag; 2019 May; 8(5):256-260. PubMed ID: 31204441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
